Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q2 2025 vs. Q1 2025
How the institutions holding Fortress Biotech, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 46 | 49 | +3 |
| Shares | 4.91M | 4.96M | +48.4K (+1.0%) |
| Value | $7.66M | $9.23M | +$1.56M (+20.4%) |
New holders (11)
Institutions that held Fortress Biotech, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Summit Financial, LLC | 1,015,844 | $1.89M | 0.04% |
| Panagora Asset Management Inc | 50,065 | $93.1K | 0.00% |
| Susquehanna International Group, LLP | 45,635 | $84.9K | 0.00% |
| XTX Topco Ltd | 22,791 | $42.4K | 0.00% |
| Two Sigma Securities, LLC | 13,635 | $25.4K | 0.00% |
| Creative Planning | 12,452 | $23.2K | 0.00% |
| GWM Advisors LLC | 11,200 | $20.8K | 0.00% |
| National Bank of Canada | 10,600 | $19.7K | 0.00% |
| R Squared Ltd | 10,171 | $18.9K | 0.01% |
| Tower Research Capital LLC (TRC) | 904 | $1.68K | 0.00% |
| Raymond James Financial Inc | 26 | $48 | 0.00% |
Sold out (8)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 1,004,365 | $1.57M |
| HB Wealth Management, LLC | 113,350 | $176.8K |
| Group One Trading, L.P. | 44,820 | $69.9K |
| Renaissance Technologies LLC | 32,000 | $49.9K |
| Ameriflex Group, Inc. | 4,400 | $6.86K |
| FMR LLC | 1,950 | $3.04K |
| Citigroup Inc | 193 | $301 |
| Wells Fargo & Company | 16 | $25 |